SCHEMBL6983447

SCHEMBL6983447

NCC1CCN(C[C@H]2COc3ccc(Cl)cc3O2)CC1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 3/20 0.52
SIGMAR1 Q99720 2/20 0.52
CA2 P00918 1/20 0.49
ADRA1D P25100 3/20 0.47
ADRA1A P35348 3/20 0.47
ADRA1B P35368 3/20 0.47
ADRA2A P08913 1/20 0.47
ADRA2B P18089 1/20 0.47
ADRA2C P18825 1/20 0.47
SCN1A P35498 1/20 0.47
SCN2A Q99250 1/20 0.47
SCN3A Q9NY46 1/20 0.47
DRD2 P14416 1/20 0.47
DRD4 P21917 1/20 0.47
HTR2C P28335 1/20 0.47
DRD3 P35462 1/20 0.47
HRH4 Q9H3N8 1/20 0.45
HRH3 Q9Y5N1 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6982237 1.00 HTR1A (0.52) HTR1ASIGMAR1CA2ADRA1DADRA1A
SCHEMBL8105769 0.85 HTR1A (0.52) HTR1ASIGMAR1CA2ADRA1DADRA1A
SCHEMBL8105772 0.85 HTR1A (0.52) HTR1ASIGMAR1CA2ADRA1DADRA1A
SCHEMBL9458265 0.83 HTR1A (0.72) HTR1ASIGMAR1ADRA1DADRA1AADRA1B
SCHEMBL8111361 0.82 HTR1A (0.49) HTR1ASIGMAR1ADRA1DADRA1AADRA1B
SCHEMBL8111366 0.82 HTR1A (0.49) HTR1ASIGMAR1ADRA1DADRA1AADRA1B
SCHEMBL8321140 0.82 HTR1A (0.50) HTR1ASIGMAR1ADRA1DADRA1AADRA1B
Bromide SCHEMBL10370436 0.82 HTR1A (0.70) HTR1ASIGMAR1ADRA1DADRA1AADRA1B
SCHEMBL8383294 0.82 CA2 (0.48) HTR1ASIGMAR1CA2ADRA1DADRA1A
SCHEMBL10833179 0.81 HTR1A (0.52) HTR1ASIGMAR1ADRA1DADRA1AADRA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0839145-B1 HETEROCYCLYLCARBOXAMIDE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS ABBOTT GMBH & CO KG (DE) 2003-11-05 EP disclosed
CN-1071755-C Heterocyclylcarboxamide derivatives and their use as therapeutic agents KNOLL AG (DE) 2001-09-26 CN disclosed
US-6136825-A ANTIDEPRESSANTS AND CENTRAL NERVOUS SYSTEM AGENTS KNOLL AKTIENGESELLSCHAFT 2000-10-24 US disclosed
CN-1247537-A Sulfonamide compounds having 5-HT receptor activity KNOLL AG (DE) 2000-03-15 CN disclosed
EP-0948498-A1 SULFONAMIDE COMPOUNDS HAVING 5-HT RECEPTOR ACTIVITY KNOLL AKTIENGESELLSCHAFT (DE) 1999-10-13 EP disclosed
US-5935973-A AFFINITY FOR 5-HT1A, ALPHA1, ALPHA2 AND/OR D2 RECEPTORS; ANTIDEPRESSANTS, ANXIOLYTIC AGENTS, PSYCHOSES, DYSKINESIAS, PARKINSON'S DISEASE, HYPOTENSIVE AGENTS, TOURETTE'S SYNDROME, OBSESSIVE-COMPULSIVE BEHAVIOUR, PANIC ATTACKS, SOCIAL PHOBIAS KNOLL AKTIENGESELLSCHAFT (DE) 1999-08-10 US disclosed
CN-1190967-A Heterocyclylcarboxamide derivatives and their use as therapeutic agents KNOLL AG (DE) 1998-08-19 CN disclosed
WO-1998029411-A1 SULFONAMIDE COMPOUNDS HAVING 5-HT RECEPTOR ACTIVITY KNOLL AKTIENGESELLSCHAFT (DE) 1998-07-09 WO disclosed
EP-0839145-A1 HETEROCYCLYLCARBOXAMIDE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS Knoll AG (DE) 1998-05-06 EP disclosed
WO-1997003071-A1 HETEROCYCLYLCARBOXAMIDE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS KNOLL AKTIENGESELLSCHAFT (DE) 1997-01-30 WO disclosed